| Hodgkin's Disease |
69.3% |
| Anaplastic Large Cell Lymphoma T- And Null-cell Types |
5.5% |
| Diffuse Large B-cell Lymphoma |
3.6% |
| Product Used For Unknown Indication |
3.6% |
| Hodgkin's Disease Refractory |
3.3% |
| Lymphoma |
2.2% |
| Non-hodgkin's Lymphoma |
1.9% |
| T-cell Lymphoma |
1.9% |
| Hodgkin's Disease Recurrent |
1.7% |
| Mycosis Fungoides |
1.4% |
| Non-hodgkin's Lymphoma Recurrent |
1.4% |
| Angioimmunoblastic T-cell Lymphoma |
0.8% |
| Anaplastic Large-cell Lymphoma |
0.6% |
| Human T-cell Lymphotropic Virus Type I Infection |
0.6% |
| Pseudolymphoma |
0.6% |
| Small Cell Lung Cancer Stage Unspecified |
0.6% |
| B-cell Lymphoma |
0.3% |
| Mesothelioma |
0.3% |
| Neoplasm Recurrence |
0.3% |
| Ovarian Epithelial Cancer |
0.3% |
